20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Schistosomiasis is a parasitic disease caused by trematode worms of the genus Schistosoma and affects over 200 million people worldwide. The control and treatment of this neglected tropical disease is based on a single drug, praziquantel, which raises concerns about the development of drug resistance. This, and the lack of efficacy of praziquantel against juvenile worms, highlights the urgency for new antischistosomal therapies. In this review we focus on innovative approaches to the identification of antischistosomal drug candidates, including the use of automated assays, fragment-based screening, computer-aided and artificial intelligence-based computational methods. We highlight the current developments that may contribute to optimizing research outputs and lead to more effective drugs for this highly prevalent disease, in a more cost-effective drug discovery endeavor.

          Related collections

          Most cited references384

          • Record: found
          • Abstract: found
          • Article: not found

          Gene Ontology: tool for the unification of biology

          Genomic sequencing has made it clear that a large fraction of the genes specifying the core biological functions are shared by all eukaryotes. Knowledge of the biological role of such shared proteins in one organism can often be transferred to other organisms. The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells is accumulating and changing. To this end, three independent ontologies accessible on the World-Wide Web (http://www.geneontology.org) are being constructed: biological process, molecular function and cellular component.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            NIH Image to ImageJ: 25 years of image analysis

            For the past twenty five years the NIH family of imaging software, NIH Image and ImageJ have been pioneers as open tools for scientific image analysis. We discuss the origins, challenges and solutions of these two programs, and how their history can serve to advise and inform other software projects.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Deep learning.

              Deep learning allows computational models that are composed of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and many other domains such as drug discovery and genomics. Deep learning discovers intricate structure in large data sets by using the backpropagation algorithm to indicate how a machine should change its internal parameters that are used to compute the representation in each layer from the representation in the previous layer. Deep convolutional nets have brought about breakthroughs in processing images, video, speech and audio, whereas recurrent nets have shone light on sequential data such as text and speech.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                31 May 2021
                2021
                : 12
                : 642383
                Affiliations
                [1] 1 LabMol – Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás – UFG , Goiânia, Brazil
                [2] 2 LaBECFar – Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz , Rio de Janeiro, Brazil
                [3] 3 Diamond Light Source Ltd. , Didcot, United Kingdom
                [4] 4 Research Complex at Harwell , Didcot, United Kingdom
                [5] 5 The Rosalind Franklin Institute , Harwell, United Kingdom
                [6] 6 Division of Structural Biology, The Wellcome Centre for Human Genetic, University of Oxford , Oxford, United Kingdom
                [7] 7 Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine , London, United Kingdom
                Author notes

                Edited by: Thiago Almeida Pereira, Stanford University, United States

                Reviewed by: Conor R. Caffrey, University of California, San Diego, United States; Lizandra Guidi Magalhães, University of Franca, Brazil; Douglas Pires, The University of Melbourne, Australia

                *Correspondence: Carolina H. Andrade, carolina@ 123456ufg.br

                This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2021.642383
                8203334
                34135888
                1a6444a6-e8c6-4aaf-8bac-c2df3aa1b963
                Copyright © 2021 Moreira-Filho, Silva, Dantas, Gomes, Souza Neto, Brandao-Neto, Owens, Furnham, Neves, Silva-Junior and Andrade

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 15 December 2020
                : 30 April 2021
                Page count
                Figures: 4, Tables: 4, Equations: 0, References: 388, Pages: 29, Words: 14914
                Funding
                Funded by: Conselho Nacional de Desenvolvimento Científico e Tecnológico 10.13039/501100003593
                Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 10.13039/501100002322
                Funded by: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 10.13039/501100004586
                Funded by: Fundação de Amparo à Pesquisa do Estado de Goiás 10.13039/501100005285
                Funded by: Fundação Oswaldo Cruz 10.13039/501100006507
                Categories
                Immunology
                Review

                Immunology
                schistosomiasis,drug discovery,artificial intelligence,fragment-based drug discovery,phenotypic screening,target-based screening

                Comments

                Comment on this article